Recombinant antigens

ospC
for Borrelia garinii, Borrelia afzelii and Borrelia burgdorferi

Outer membrane protein ospC is essential for the invasive strategy of the pathogenic spirochete responsible for Lyme disease. Detection of anti-OspC borreliacidal antibodies, especially IgM antibodies, in early Lyme borreliosis sera provides additional evidence that borreliacidal antibody detection may be useful for the serodiagnosis of early Lyme borreliosis.

NAME
Ospc
DESCRIPTION
Outer membrane antigen
GEN
ospC
PURITY
>95% by observation on SDS-PAGE electrophoresis
Formats

Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format

* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.

References of Recombinant antigen ospC

RAG0034
(B. garinii)

SOURCE
E. coli
APPLICATIONS
WB Western Blot, DB: Dot Blot, IE: Indirect ELISA, DE: positive control in Direct ELISA, CLIA: Chemiluminescent immunoassay, LF: Lateral-Flow

RAG0042
(B. afzelii)

SOURCE
E. coli
APPLICATIONS
WB Western Blot, DB: Dot Blot, IE: Indirect ELISA, DE: positive control in Direct ELISA, CLIA: Chemiluminescent immunoassay, LF: Lateral-Flow

RAG0043
(B. burgdorferi)

SOURCE
E. coli
APPLICATIONS
WB Western Blot, DB: Dot Blot, IE: Indirect ELISA, DE: positive control in Direct ELISA, CLIA: Chemiluminescent immunoassay, LF: Lateral-Flow

Folletos

Videos

Related proteins

flagellin B

  • RAG0054 (B. afzelii)
  • RAG0055 (B. burgdorferi)
  • RAG0072 (B. garinii)

Recombinant antigen ospC for Borrelia garinii, Borrelia afzelii and Borrelia burgdorferi
Internal central portion of 41 kDa flagelline B protein (p41)

SEE MORE

VlsE

  • RAG0022 (B. garinii, quimera)
  • RAG0102 (B. afzelii)
  • RAG0027 (B. burgdorferi, quimera)

Recombinant antigen ospC for Borrelia garinii, Borrelia afzelii and Borrelia burgdorferi
Major variable Surface antigen

SEE MORE

Reagent sheet

NAME
ospC
DESCRIPTION
Outer membrane antigen
PURITY
>95% by observation on SDS-PAGE electrophoresis
Formats

Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format

* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.

Join as a distributor